Business Wire

Fluence Launches SPYDR 2h, Enabling Commercial Cannabis Cultivators to Produce Higher Crop Yields

Share

Fluence by OSRAM (Fluence), a leading global provider of energy-efficient LED lighting solutions for commercial cannabis and food production, launched its high-intensity fixture SPYDR 2h. The latest addition to Fluence’s SPYDR series, the high-output solution produces a photosynthetic photon flux (PPF) of 2,100 μmol/s, a 24% increase over previous fixtures.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220216005406/en/

Fluence designed the cutting-edge SPYDR 2h solution for indoor, multi-tier commercial cannabis cultivators aiming to optimize their growing environments, achieve greater crop yields and grow higher quality crops. The fixture offers high-intensity lighting, precise uniformity, increased efficiencies and features Fluence’s PhysioSpec™ BROAD R4 indoor white spectrum with efficacy of 2.6 μmol/J at 277V AC. In typical multi-tier rack systems, photosynthetic photon flux density (PPFD) levels of up to 1,500 μmol/m2/s can be achieved. The multi-tier luminaires are also easy to mount for a quick and flexible installation.

“High-intensity lighting is top-of-mind for commercial cannabis operations seeking to increase crop yields,” said Jordon Musser, chief product officer for Fluence. “We’re proud to provide growers the next generation in our SPYDR series—a higher-performing lighting solution—to boost their cultivation goals as they revolutionize operations through advanced cultivation strategies.”

Fluence’s fixtures are backed by science: The company’s multiyear global cannabis research trials demonstrate higher lighting intensities maximize crop yields. SYPDR 2h’s capability to increase PPF by more than 20% not only affords growers the opportunity to improve crop yield, but to also hone plant production to achieve specific traits such as higher THC percentages and more potent terpene profiles.

“Fluence is excited to introduce SPYDR 2h to cannabis cultivators throughout the world,” said David Cohen, CEO of Fluence. “As more states and countries introduce cannabis legislation—and the industry’s existing leaders evolve their cultivation environments—Fluence’s high-intensity LED technology offers cannabis customers uniformity and greater control within their facilities. We support cultivators every step of the way in implementing new solutions like SPYDR 2h to help them grow smarter, resulting in higher yields and better-quality cannabis crops.”

For more information about SPYDR 2h and Fluence’s extended portfolio of LED solutions, visit www.fluence.science.

About Fluence by OSRAM

Fluence Bioengineering, Inc., a wholly-owned subsidiary of OSRAM, creates powerful and energy-efficient LED lighting solutions for commercial crop production and research applications. Fluence is a leading LED lighting supplier in the global cannabis market and is committed to enabling more efficient crop production with the world’s top vertical farms and greenhouse produce growers. Fluence global headquarters are based in Austin, Texas, with its EMEA headquarters in Rotterdam, Netherlands. For more information about Fluence, visit https://fluence.science.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For Fluence,
Emma Chase
pr@fluencebioengineering.com
C: 512-917-4319

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

TVS Motor Announces Sudarshan Venu as Chairman of the Company Effective August 25, 20256.6.2025 13:31:00 EEST | Press release

TVS Motor Company announced today that The Board of Directors unanimously named Mr Sudarshan Venu as incoming Chairman of the Company, in recognition of his exemplary contributions to the Company’s sustained growth and strategic development during his tenure as Director. Effective August 25, 2025, Mr Sudarshan Venu will be appointed as Chairman and Managing Director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606441596/en/ Sudarshan Venu, Managing Director, TVS Motor Company. Its current chairman, Sir Ralf Speth, has informed The Board of Directors that he will not be seeking re-appointment as a company Director at the upcoming Annual General Meeting (AGM). Consequently, he will step down as Chairman of the Company at the close of the AGM on August 22, 2025. The Board will also be appointing Sir Ralf Speth as Chief Mentor of the Company for a period of three years effective August 23, 2025, ensuring continued benefit

Budweiser Kicks Off New “Celebration in the Making” Global Platform for FIFA Club World Cup 2025™6.6.2025 11:00:00 EEST | Press release

Today, Budweiser (Brussel:ABI) (BMV:ANB) (JSE:ANH) (NYSE:BUD) unveils its new global platform “Celebration in the Making” and full campaign details as the Official Global Beer Sponsor of the FIFA Club World Cup 2025™. This summer, as football supporters around the globe bring their energy to the groundbreaking tournament, Budweiser will be there to elevate celebrations at every stage – from the opening touch to the final whistle, and beyond. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606379419/en/ Budweiser Kicks Off New “Celebration in the Making” Global Platform for FIFA Club World Cup 2025™ To inspire celebrations from the start, Budweiser is officially kicking off the platform with a new film set to an iconic score, and announces the return of its acclaimed “Bring Home The Bud” campaign to deliver the ultimate prize of free beer for the winning club* and its supporters. Budweiser will also leverage exclusive FIFA-

SES Announces Appointment of New CFO6.6.2025 09:30:00 EEST | Press release

SES today announced its Board of Directors has appointed Elisabeth (Lisa) Pataki as Chief Financial Officer (CFO), effective 16 June 2025. Lisa is a progressive finance executive with over 20 years of experience at various publicly listed multi-national aerospace and defence companies with strong background in company transformation and investment strategies. She will succeed Sandeep Jalan who has been SES’s CFO since May 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250605243814/en/ Lisa Pataki The SES Board acknowledges Sandeep’s contribution to SES and wishes him success in future endeavours. Lisa will work closely with Sandeep to ensure a smooth handover before he leaves on 31 July 2025. “I would like to thank Sandeep for his steadfast leadership over the last five years where he has driven continuous execution improvement and transformation while strengthening the company’s balance sheet with a competitive cost o

RAD 2025: Long-Term Data on Nemluvio ® (nemolizumab) Demonstrate its Favorable Safety Profile and Sustained and Increased Improvements in Itch and Skin Lesions in Patients With Atopic Dermatitis up to Two Years6.6.2025 08:00:00 EEST | Press release

Galderma (SIX: GALD) today announced two-year data from a new interim analysis of a long-term extension study investigating the safety and efficacy of Nemluvio in moderate-to-severe atopic dermatitis. The data show that Nemluvio is well tolerated, with no new safety signals identified, reinforcing its rapid onset of action and demonstrating sustained and increased improvements in symptoms including itch and skin lesions with prolonged treatment up to two years.1 These data will be presented in a late-breaker abstract at the Revolutionizing Atopic Dermatitis (RAD) Conference, taking place from June 6-7, 2025. “With Nemluvio now being launched in several countries, it’s so encouraging that we continue to see its robust evidence base expand. Long-term data is pivotal to this, highlighting the profound impact this innovative treatment can have in atopic dermatitis well into the future.” BALDO SCASSELLATI SFORZOLINI, M.D., PHD. GLOBAL HEAD OF RESEARCH & DEVELOPMENT GALDERMA Atopic dermatiti

BGO Announces US$5.1 Billion Capital Raise for Its Asia Value-Add Real Estate Strategy, Marking Largest Closed-End Fundraise in Firm’s History5.6.2025 23:00:00 EEST | Press release

BGO today announced the final close of BentallGreenOak Asia IV (“BGO Asia Fund IV” or the “Fund”), its flagship Asia-focused value-add real estate strategy, raising over US$5.1 billion in total capital commitments for the Fund and co-investment sidecars. The Fund represents the largest closed-end capital raise in BGO’s history, underscoring the firm’s history and reputation as a premier global real estate investment manager in Asian markets. BGO Asia Fund IV targets value-add opportunities in office, hospitality, and logistics assets across Japan, South Korea, Australia, and Singapore. Japan represents a central pillar of our investment strategy, driven by regulatory reforms and corporate governance shifts that are catalyzing an estimated US$3 trillion in non-core asset divestitures. “Japan is undergoing a profound transformation, and we see strong, sustained tailwinds across the region,” said Fred Schmidt, Managing Partner and Chairman of Asia, BGO. “Tokyo is one of the world’s larges

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye